Paratek’s Phase 3 Studies of NUZYRA Published in Medical...

Wednesday's announcement comes after the company revealed on Tuesday that NUZYRA is now commercially available in...

February 6th, 2019

Transdermal Delivery Technology Improving Bioavailability in Cannabinoid Therapeutics

Technology that improves the delivery of cannabinoids to the brain is critical to growth in the...

February 5th, 2019

Checkpoint Inhibitors Driving the Immunotherapy Market

The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.

February 3rd, 2019

Prana Granted First MSA Orphan Drug Designation from FDA

Prana revealed Thursday that the FDA has granted it the first orphan drug designation to treat...

January 31st, 2019

Video Round-Up: Biotech Showcase Conference 2019

The Biotech Showcase this year took place in San Francisco and gave international and local guests...

January 30th, 2019

Healios Focusing on Stem Cell Trials in Asia

David Smith, director at Healios, talks about his company’s focus, stem cell trials and what the...

January 29th, 2019

Notes from the Floor: Cantech Investment Conference, Day 1

The Investing News Network brings you a recap from day one of the two-day Cantech Investment...

January 29th, 2019

Get the latest Life Science Investing stock information

Get the latest information about companies associated with Life Science Investing Delivered directly to your inbox.

Life Science Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive communication from those companies using the contact information you provide. And remember you can unsubscribe at any time.